ライフサイエンスコーパス: severe acute respiratory syndrome

1 ediate global urgency, such as influenza and severe acute respiratory syndrome.

2 patic infections such as influenza virus and severe acute respiratory syndrome.

3 ric diseases in animals and humans including severe acute respiratory syndrome.

4 ory disease in humans and animals, including severe acute respiratory syndrome.

5 with MERS closely matches that of those with severe acute respiratory syndrome.

6 emergence of human disease epidemics such as severe acute respiratory syndrome, AIDS, dengue, and inf

7 ding HIV and the coronavirus associated with severe acute respiratory syndrome, and is also exploited

8 The spike (S) protein of severe acute respiratory syndrome associated coronavirus

9 ting and characterizing new pathogens (e.g., severe acute respiratory syndrome-associated coronavirus

10 The genome of the severe acute respiratory syndrome-associated coronavirus

11 a two-segmented virus expressing GFP and the severe acute respiratory syndrome-associated coronavirus

12 The international outbreak of the severe acute respiratory syndrome-associated coronavirus

13 In 2002, severe acute respiratory syndrome-associated coronavirus

14 MAb 201 is a severe acute respiratory syndrome-associated coronavirus

15 r coronaviruses, the membrane (M) protein of severe acute respiratory syndrome-associated coronavirus

16 animal species that can be infected with the severe acute respiratory syndrome-associated coronavirus

17 The Spike (S) protein of the severe acute respiratory syndrome-associated coronavirus

18 Severe acute respiratory syndrome-associated coronavirus

19 Although the severe acute respiratory syndrome-associated coronavirus

20 gens, including the recently emerged viruses severe acute respiratory syndrome-associated coronavirus

21 read of infectious diseases, including SARS (severe acute respiratory syndrome), avian influenza, and

22 ections, including varicella, influenza, and severe acute respiratory syndrome, can be associated wit

23 and biological evaluation of peptidomimetic severe acute respiratory syndrome chymotrypsin-like prot

24 nase) is required for the replication of the severe acute respiratory syndrome coronavirus (SARS CoV)

25 Like other coronaviruses, severe acute respiratory syndrome coronavirus (SARS CoV)

26 Intranasal inhalation of the severe acute respiratory syndrome coronavirus (SARS CoV)

27 of several dangerous pathogens (e.g. HIV and severe acute respiratory syndrome coronavirus (SARS)) vi

28 Severe acute respiratory syndrome coronavirus (SARS-CoV)

29 The severe acute respiratory syndrome coronavirus (SARS-CoV)

30 a number of higher-affinity variants of the severe acute respiratory syndrome coronavirus (SARS-CoV)

31 In the 2002-2003 severe acute respiratory syndrome coronavirus (SARS-CoV)

32 ne-protective and immunopathogenic events in severe acute respiratory syndrome coronavirus (SARS-CoV)

33 failure was caused by a newly emerged virus, severe acute respiratory syndrome coronavirus (SARS-CoV)

34 Severe acute respiratory syndrome coronavirus (SARS-CoV)

35 The human severe acute respiratory syndrome coronavirus (SARS-CoV)

36 Severe acute respiratory syndrome coronavirus (SARS-CoV)

37 The severe acute respiratory syndrome coronavirus (SARS-CoV)

38 The most prominent of these viruses is the severe acute respiratory syndrome coronavirus (SARS-CoV)

39 The newly emerging severe acute respiratory syndrome coronavirus (SARS-CoV)

40 Severe acute respiratory syndrome coronavirus (SARS-CoV)

41 In the case of the severe acute respiratory syndrome coronavirus (SARS-CoV)

42 The severe acute respiratory syndrome coronavirus (SARS-CoV)

43 Severe acute respiratory syndrome coronavirus (SARS-CoV)

44 The severe acute respiratory syndrome coronavirus (SARS-CoV)

45 haracterized the cellular immune response to severe acute respiratory syndrome coronavirus (SARS-CoV)

46 mechanisms used by different viruses such as severe acute respiratory syndrome coronavirus (SARS-CoV)

47 Severe acute respiratory syndrome coronavirus (SARS-CoV)

48 nsp1 protein of severe acute respiratory syndrome coronavirus (SARS-CoV)

49 atory viruses, including influenza virus and severe acute respiratory syndrome coronavirus (SARS-CoV)

50 onverting enzyme 2 (hACE2), the receptor for severe acute respiratory syndrome coronavirus (SARS-CoV)

51 Infection by severe acute respiratory syndrome coronavirus (SARS-CoV)

52 Viruses such as hepatitis C and the severe acute respiratory syndrome coronavirus (SARS-CoV)

53 Highly pathogenic severe acute respiratory syndrome coronavirus (SARS-CoV)

54 The severe acute respiratory syndrome coronavirus (SARS-CoV)

55 The severe acute respiratory syndrome coronavirus (SARS-CoV)

56 Severe acute respiratory syndrome coronavirus (SARS-CoV)

57 Infection of humans with the severe acute respiratory syndrome coronavirus (SARS-CoV)

58 Severe acute respiratory syndrome coronavirus (SARS-CoV)

59 The severe acute respiratory syndrome coronavirus (SARS-CoV)

60 observed when gene expression profiles from severe acute respiratory syndrome coronavirus (SARS-CoV)

61 Zoonotic severe acute respiratory syndrome coronavirus (SARS-CoV)

62 immunodeficiency virus (HIV), influenza, and severe acute respiratory syndrome coronavirus (SARS-CoV)

63 The severe acute respiratory syndrome coronavirus (SARS-CoV)

64 It is believed that a novel coronavirus, severe acute respiratory syndrome coronavirus (SARS-CoV)

65 Using severe acute respiratory syndrome coronavirus (SARS-CoV)

66 The severe acute respiratory syndrome coronavirus (SARS-CoV)

67 ation of nsp3a, the N-terminal domain of the severe acute respiratory syndrome coronavirus (SARS-CoV)

68 The highly pathogenic severe acute respiratory syndrome coronavirus (SARS-CoV)

69 The proteins encoded by gene 7 of the severe acute respiratory syndrome coronavirus (SARS-CoV)

70 re nonstructural protein-15 (nsp15) from the severe acute respiratory syndrome coronavirus (SARS-CoV)

71 We found a known inhibitor of severe acute respiratory syndrome coronavirus (SARS-CoV)

72 Sequence analysis of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)

73 e characterized the structures of N-NTD from severe acute respiratory syndrome coronavirus (SARS-CoV)

74 In 2003, severe acute respiratory syndrome coronavirus (SARS-CoV)

75 Severe acute respiratory syndrome coronavirus (SARS-CoV)

76 The severe acute respiratory syndrome coronavirus (SARS-CoV)

77 e glycoprotein, termed the spike protein, of severe acute respiratory syndrome coronavirus (SARS-CoV)

78 The spike (S) glycoprotein of severe acute respiratory syndrome coronavirus (SARS-CoV)

79 lphacoronavirus and Betacoronavirus, such as severe acute respiratory syndrome coronavirus (SARS-CoV)

80 The severe acute respiratory syndrome coronavirus (SARS-CoV)

81 The spike (S) protein of severe acute respiratory syndrome coronavirus (SARS-CoV)

82 Replication of the genomic RNA of severe acute respiratory syndrome coronavirus (SARS-CoV)

83 phylogenetically divergent counterpart from severe acute respiratory syndrome coronavirus (SARS-CoV)

84 The recently emerged severe acute respiratory syndrome coronavirus (SARS-CoV)

85 ted residues in pFPs of two other beta-CoVs, severe acute respiratory syndrome coronavirus (SARS-CoV)

86 Murine hepatitis virus (MHV) and severe acute respiratory syndrome coronavirus (SARS-CoV)

87 n-like protease (SARS-3CLpro) inhibitors for severe acute respiratory syndrome coronavirus (SARS-CoV)

88 (IgG1), a human monoclonal antibody against severe acute respiratory syndrome coronavirus (SARS-CoV)

89 we report the three-dimensional structure of severe acute respiratory syndrome coronavirus (SARS-CoV)

90 Severe acute respiratory syndrome coronavirus (SARS-CoV)

91 localization in Vero cells infected with the severe acute respiratory syndrome coronavirus (SARS-CoV)

92 We have expressed and characterized the severe acute respiratory syndrome coronavirus (SARS-CoV)

93 The severe acute respiratory syndrome coronavirus (SARS-CoV)

94 Severe acute respiratory syndrome coronavirus (SARS-CoV)

95 Infection by severe acute respiratory syndrome coronavirus (SARS-CoV)

96 Severe acute respiratory syndrome coronavirus (SARS-CoV)

97 Severe acute respiratory syndrome coronavirus (SARS-CoV)

98 RS was identified to be a novel coronavirus, severe acute respiratory syndrome coronavirus (SARS-CoV)

99 bat coronavirus which is much closer to the severe acute respiratory syndrome coronavirus (SARS-CoV)

100 The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV)

101 The spread of severe acute respiratory syndrome coronavirus (SARS-CoV)

102 The severe acute respiratory syndrome coronavirus (SARS-CoV)

103 Severe acute respiratory syndrome coronavirus (SARS-CoV)

104 The sudden emergence of severe acute respiratory syndrome coronavirus (SARS-CoV)

105 omain (RBD) of the spike (S) glycoprotein of severe acute respiratory syndrome coronavirus (SARS-CoV)

106 ced by its counterpart from the N protein of severe acute respiratory syndrome coronavirus (SARS-CoV)

107 By comparing what is known about severe acute respiratory syndrome coronavirus (SARS-CoV)

108 against the papain-like protease (PLpro) of severe acute respiratory syndrome coronavirus (SARS-CoV)

109 Severe acute respiratory syndrome coronavirus (SARS-CoV)

110 The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV)

111 The RNA-synthesizing machinery of the severe acute respiratory syndrome Coronavirus (SARS-CoV)

112 of the first highly pathogenic coronavirus, severe acute respiratory syndrome coronavirus (SARS-CoV)

113 pro were determined and compared to those of severe acute respiratory syndrome coronavirus (SARS-CoV)

114 coronaviruses (CoVs), including ancestors of severe acute respiratory syndrome coronavirus (SARS-CoV)

115 requirement slightly different from that of severe acute respiratory syndrome coronavirus (SARS-CoV)

116 Infection with severe acute respiratory syndrome coronavirus (SARS-CoV)

117 LXCXE/D) in the majority of the Nsp15 of the severe acute respiratory syndrome coronavirus (SARS-CoV)

118 The severe acute respiratory syndrome coronavirus (SARS-CoV,

119 (EC(50) 39 microM) against cowpox virus and severe acute respiratory syndrome coronavirus (SARSCoV)

120 Severe acute respiratory syndrome coronavirus (SCoV) 7a

121 Severe acute respiratory syndrome coronavirus (SCoV) acc

122 he present study showed the association of a severe acute respiratory syndrome coronavirus (SCoV) acc

123 Analysis of severe acute respiratory syndrome coronavirus (SCoV) by

124 5'UTRs) from mouse hepatitis virus (MHV) and severe acute respiratory syndrome coronavirus (SCoV) wer

125 lines and primary cells examined, productive severe acute respiratory syndrome coronavirus (Urbani st

126 The severe acute respiratory syndrome coronavirus accessory

127 s which carry a macro domain: Coronaviridae (severe acute respiratory syndrome coronavirus and human

128 to the entry pathway recently described for severe acute respiratory syndrome coronavirus and indica

129 t are important agents of disease, including severe acute respiratory syndrome coronavirus and Middle

130 The emergence of viruses such as severe acute respiratory syndrome coronavirus and Nipah

131 es of the S, M, and N structural proteins of severe acute respiratory syndrome coronavirus and two ot

132 Using severe acute respiratory syndrome coronavirus as a model

133 nslated region (3' UTR) of the genome of the severe acute respiratory syndrome coronavirus can functi

134 Severe acute respiratory syndrome coronavirus encodes se

135 The severe acute respiratory syndrome coronavirus enters cel

136 Molecular characterization of the severe acute respiratory syndrome coronavirus has reveal

137 It was recently shown that the 7a protein of severe acute respiratory syndrome coronavirus induces bi

138 icantly influence disease outcomes following severe acute respiratory syndrome coronavirus infection

139 sin RTD-1 protects mice from an experimental severe acute respiratory syndrome coronavirus infection,

140 The replication/transcription complex of severe acute respiratory syndrome coronavirus is compose

141 aring an insertion of the SR region from the severe acute respiratory syndrome coronavirus N protein

142 The NMR structure of the severe acute respiratory syndrome coronavirus nonstructu

143 notated nucleic acid-binding region (NAB) of severe acute respiratory syndrome coronavirus nonstructu

144 sidues of mNsp15 are superimposable with its severe acute respiratory syndrome coronavirus ortholog.

145 use they had no effect on the ability of the severe acute respiratory syndrome coronavirus papainlike

146 o predicted heptad repeat regions within the severe acute respiratory syndrome coronavirus S protein.

147 The severe acute respiratory syndrome coronavirus spike prot

148 DPUP has close structural similarity to the severe acute respiratory syndrome coronavirus unique dom

149 ar viral entry mechanisms (such as HIV-1 and severe acute respiratory syndrome coronavirus) can be in

150 Unlike the nsp1 protein of severe acute respiratory syndrome coronavirus, a betacor

151 uses, including henipaviruses, lyssaviruses, severe acute respiratory syndrome coronavirus, and filov

152 ad antiviral spectrum includes HIV-1, HSV-1, severe acute respiratory syndrome coronavirus, and influ

153 ith highly pathogenic avian influenza virus, severe acute respiratory syndrome coronavirus, and Middl

154 engue virus, Ebola virus, influenza A virus, severe acute respiratory syndrome coronavirus, and West

155 ratory disease were found, including (i) the severe acute respiratory syndrome coronavirus, associate

156 tick-borne encephalitis virus, rabies virus, severe acute respiratory syndrome coronavirus, human imm

157 viruses, infectious bronchitis virus and the severe acute respiratory syndrome coronavirus.

158 e disease observed in patients infected with severe acute respiratory syndrome coronavirus.

159 ng that this domain may not be unique to the severe acute respiratory syndrome coronavirus.

160 an inhibitor of the papain-like protease of severe acute respiratory syndrome coronavirus.

161 ronaviral PL(pro) domains, including that of severe acute respiratory syndrome coronavirus.

162 nstrating a much broader tissue tropism than severe acute respiratory syndrome coronavirus.

163 ted with Dengue virus, hepatitis B virus, or severe acute respiratory syndrome coronavirus.

164 s to assess the interactions between MBL and severe acute respiratory syndrome-coronavirus (SARS-CoV)

165 rburg, Nipah, Hendra, and rabies viruses and severe acute respiratory syndrome-coronavirus (SARS-CoV)

166 These data show that the entry of severe acute respiratory syndrome coronaviruses can be e

167 of the Middle East respiratory syndrome and severe acute respiratory syndrome coronaviruses for cell

168 hyl glutaminyl fluoromethyl ketones (fmk) as severe acute respiratory syndrome coronovirus (SARS-CoV)

169 The primary receptor for the human severe acute respiratory syndrome CoV (SARS) CoV is angi

170 thogenic human pathogens of zoonotic origin: severe acute respiratory syndrome CoV (SARS-CoV) and Mid

171 including DNA proofreading enzymes, and the severe acute respiratory syndrome CoV (SARS-CoV) nsp14 h

172 piratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome CoV (SARS-CoV) represe

173 ond cleavage site has been identified in the severe acute respiratory syndrome CoV (SARS-CoV) S2 doma

174 bind to its receptor, whereas the beta-CoVs severe acute respiratory syndrome CoV in group B and Mid

175 Ds from infectious bronchitis virus and from severe acute respiratory syndrome CoV revealed that, alt

176 es (CoVs) revealed an adjacent Ubl domain in severe acute respiratory syndrome CoV, Middle East respi

177 Using mice infected with SARS (severe acute respiratory syndrome)-CoV, we show that rob

178 ve cross-reactivity between MERS-CoV and the severe acute respiratory syndrome-CoV.

179 The severe acute respiratory syndrome crisis exposed serious

180 cluding Middle East respiratory syndrome and severe acute respiratory syndrome, generating significan

181 aviruses, including the etiological cause of severe acute respiratory syndrome, has significantly inc

182 ance by using data from the 2003 epidemic of severe acute respiratory syndrome in Hong Kong, People's

183 SARS (severe acute respiratory syndrome) is caused by a newly

184 d re-emerging infectious diseases, including severe acute respiratory syndrome-like coronaviruses, he

185 ory Syndrome coronavirus (MERS-CoV) causes a Severe Acute Respiratory Syndrome-like disease with appr

186 od are investigated in a simulation study of severe acute respiratory syndrome-like outbreaks.

187 The severe acute respiratory syndrome outbreak of 2002 showe

188 Most pandemics--eg, HIV/AIDS, severe acute respiratory syndrome, pandemic influenza--o

189 Severe acute respiratory syndrome rapidly decimated the

190 Severe acute respiratory syndrome (SARS) and acquired im

191 es utilize host cell cyclophilins, including severe acute respiratory syndrome (SARS) and human immun

192 that cause two emerging diseases of humans, severe acute respiratory syndrome (SARS) and Middle East

193 been discovered, including those that cause severe acute respiratory syndrome (SARS) and Middle East

194 us diseases in humans and animals, including severe acute respiratory syndrome (SARS) and Middle East

195 rus (CoV), including the causative agents of severe acute respiratory syndrome (SARS) and Middle East

196 ts that have spread internationally, such as severe acute respiratory syndrome (SARS) and the 2009 pa

197 s potentially lethal zoonotic agents causing severe acute respiratory syndrome (SARS) and the recentl

198 The pathogenesis and optimal treatments for severe acute respiratory syndrome (SARS) are unclear, al

199 s highlighted during the global emergence of severe acute respiratory syndrome (SARS) by numerous 'su

200 -term protection against future outbreaks of severe acute respiratory syndrome (SARS) caused by a nov

201 Severe acute respiratory syndrome (SARS) caused by a nov

202 a prophylactic antiviral in a mouse model of severe acute respiratory syndrome (SARS) coronavirus (Co

203 inoviruses (RhVs), enteroviruses (EnVs), and severe acute respiratory syndrome (SARS) coronavirus (Co

204 Although the initial isolates of the severe acute respiratory syndrome (SARS) coronavirus (Co

205 an unusual three-stemmed pseudoknot from the severe acute respiratory syndrome (SARS) coronavirus (Co

206 Replication of severe acute respiratory syndrome (SARS) coronavirus (SA

207 Neutralizing antibodies (NAbs) against severe acute respiratory syndrome (SARS) coronavirus (SA

208 The spike (S) protein of severe acute respiratory syndrome (SARS) coronavirus (SA

209 coronavirus (BCoV) and 339-nt 3' UTR in the severe acute respiratory syndrome (SARS) coronavirus (SC

210 Severe acute respiratory syndrome (SARS) coronavirus (SC

211 L (EC 3.4.22.15) and as an entry blocker of severe acute respiratory syndrome (SARS) coronavirus and

212 y, the predicted stem-loop IV homolog in the severe acute respiratory syndrome (SARS) coronavirus app

213 The severe acute respiratory syndrome (SARS) coronavirus enc

214 Nonstructural protein 3 of the severe acute respiratory syndrome (SARS) coronavirus inc

215 Severe acute respiratory syndrome (SARS) coronavirus inf

216 Animal models for severe acute respiratory syndrome (SARS) coronavirus inf

217 tenuated vaccine consisting of a recombinant severe acute respiratory syndrome (SARS) coronavirus lac

218 '-proximal open reading frames (ORFs) of the severe acute respiratory syndrome (SARS) coronavirus may

219 Severe acute respiratory syndrome (SARS) coronavirus non

220 The severe acute respiratory syndrome (SARS) coronavirus pap

221 The nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) coronavirus pla

222 he PLP domains of human coronavirus NL63 and severe acute respiratory syndrome (SARS) coronavirus to

223 The severe acute respiratory syndrome (SARS) coronavirus vir

224 olecule inhibitor that blocks replication of severe acute respiratory syndrome (SARS) CoV and murine

225 ting enzymes (DUBs), we confirmed that, like severe acute respiratory syndrome (SARS) CoV PLpro, HCoV

226 Studies of patients with severe acute respiratory syndrome (SARS) demonstrate tha

227 Severe acute respiratory syndrome (SARS) emerged as a hu

228 Severe acute respiratory syndrome (SARS) emerged in Nove

229 The severe acute respiratory syndrome (SARS) epidemic was ca

230 The severe acute respiratory syndrome (SARS) epidemic was ch

231 The outbreak of severe acute respiratory syndrome (SARS) in 2003 was con

232 ng that occurred during the 2003 outbreak of severe acute respiratory syndrome (SARS) in Hong Kong, C

233 To monitor severe acute respiratory syndrome (SARS) infection, a co

234 Severe acute respiratory syndrome (SARS) is a newly emer

235 Severe acute respiratory syndrome (SARS) is a significan

236 Severe acute respiratory syndrome (SARS) is an emerging

237 Severe acute respiratory syndrome (SARS) is an infectiou

238 Severe acute respiratory syndrome (SARS) is an infectiou

239 Severe acute respiratory syndrome (SARS) is caused by a

240 Severe acute respiratory syndrome (SARS) is caused by an

241 Severe acute respiratory syndrome (SARS) is characterize

242 Although the outbreak of the severe acute respiratory syndrome (SARS) is currently ov

243 Development of vaccines to prevent severe acute respiratory syndrome (SARS) is limited by t

244 The causative agent of severe acute respiratory syndrome (SARS) is the SARS-ass

245 The causative agent of severe acute respiratory syndrome (SARS) is the SARS-ass

246 An epidemic of Severe Acute Respiratory Syndrome (SARS) led to the iden

247 imization of a lead dipeptide-like series of severe acute respiratory syndrome (SARS) main protease (

248 Prompted by the severe acute respiratory syndrome (SARS) outbreak in 200

249 icture was remarkably similar to that of the severe acute respiratory syndrome (SARS) outbreak in 200

250 The severe acute respiratory syndrome (SARS) outbreak of 200

251 inflammatory glucocorticoids in the lungs of severe acute respiratory syndrome (SARS) patients are un

252 s lung pathology similar to that observed in severe acute respiratory syndrome (SARS) patients.

253 Severe acute respiratory syndrome (SARS) presented as an

254 Severe acute respiratory syndrome (SARS) remains a signi

255 nal experiments revealed, unexpectedly, that severe acute respiratory syndrome (SARS) S-mediated entr

256 rious concerns over the risk of leaking live severe acute respiratory syndrome (SARS) viruses.

257 Severe acute respiratory syndrome (SARS) was a worldwide

258 Most notable is severe acute respiratory syndrome (SARS), a lower respir

259 ic health emergencies involving anthrax, the severe acute respiratory syndrome (SARS), and shortages

260 coronaviruses, including the one that caused severe acute respiratory syndrome (SARS), cause signific

261 o be critical factors in the pathogenesis of severe acute respiratory syndrome (SARS), caused by a co

262 The severe acute respiratory syndrome (SARS), caused by a no

263 Severe acute respiratory syndrome (SARS), caused by a no

264 ing human pathogens hepatitis C virus (HCV), Severe acute respiratory syndrome (SARS), coxsackie viru

265 ses (CoVs), including the causative agent of severe acute respiratory syndrome (SARS), encode a nucle

266 In the outbreak of severe acute respiratory syndrome (SARS), many patients

267 eginning of the 2003 Singaporean outbreak of Severe Acute Respiratory Syndrome (SARS), providing new

268 The pathogenic agent responsible for severe acute respiratory syndrome (SARS), the SARS coron

269 In view of a recent spread of severe acute respiratory syndrome (SARS), there is a hig

270 Severe acute respiratory syndrome (SARS), which is cause

271 Specifically, infectious clones of the severe acute respiratory syndrome (SARS)-associated coro

272 In 2002, severe acute respiratory syndrome (SARS)-coronavirus (Co

273 pathologic features observed in the lungs of severe acute respiratory syndrome (SARS)-coronavirus-inf

274 Here, we demonstrate for severe acute respiratory syndrome (SARS)-CoV an RNA synt

275 Human coronaviruses, most notably severe acute respiratory syndrome (SARS)-CoV and Middle

276 enic human coronaviruses (CoVs), such as the severe acute respiratory syndrome (SARS)-CoV and the Mid

277 Structural data for the severe acute respiratory syndrome (SARS)-CoV E protein s

278 d that HCoV-NL63 and the genetically distant severe acute respiratory syndrome (SARS)-CoV employ the

279 demonstrate that engineered inactivation of severe acute respiratory syndrome (SARS)-CoV ExoN activi

280 The severe acute respiratory syndrome (SARS)-CoV was identif

281 des analogous to the aromatic domains of the severe acute respiratory syndrome (SARS)-CoV, mouse hepa

282 Unlike severe acute respiratory syndrome (SARS)-CoV, which excl

283 e significantly higher than IFN induction by severe acute respiratory syndrome (SARS)-CoV.

284 nthetic replicating life form, a 29.7-kb bat severe acute respiratory syndrome (SARS)-like coronaviru

285 Bats harbor severe acute respiratory syndrome (SARS)-like coronaviru

286 as received considerable attention since the severe acute respiratory syndrome (SARS)-like CoV was id

287 e coronavirus (MERS-CoV) caused outbreaks of severe acute respiratory syndrome (SARS)-like illness wi

288 HV-A59 background were able to reproduce the severe acute respiratory syndrome (SARS)-like pathology

289 Focusing on the severe acute respiratory syndrome (SARS)-like viruses, t

290 central segment of the previously annotated severe acute respiratory syndrome (SARS)-unique domain (

291 histories, including Ebola, influenza A, and severe acute respiratory syndrome (SARS).

292 ators (OR = 0.12; 95% CI: 0.06-0.26) against severe acute respiratory syndrome (SARS).

293 ome and a predictor of mortality in cases of severe acute respiratory syndrome (SARS).

294 for an unknown emerging illness, later named severe acute respiratory syndrome (SARS).

295 ase (PLpro) from the coronavirus that causes severe acute respiratory syndrome (SARS-CoV).

296 cellular receptor for the causative agent of severe-acute respiratory syndrome (SARS), SARS-CoV (coro

297 infections with epidemic potential, such as severe acute respiratory syndrome, swine-origin influenz

298 Herein, we show that the E protein in the severe acute respiratory syndrome virus has only one TM

299 the mutations onto the crystal structure of severe acute respiratory syndrome virus nsp10 identified

300 Severe acute respiratory syndrome with high mortality ra